\setlength{\LTpost}{0mm}
\begin{longtable}{llrrrrr}
\toprule
\multicolumn{2}{c}{ATC sub-group} & \multicolumn{2}{c}{\# of users} & \multicolumn{3}{c}{Cox hazard risk (HR) estimates} \\ 
\cmidrule(lr){1-2} \cmidrule(lr){3-4} \cmidrule(lr){5-7}
symbol & description & non-PD users & PD users & HR & 95\% CI & FDR p-value\textsuperscript{1} \\ 
\midrule
\multicolumn{7}{l}{drugs decreasing PD risk} \\ 
\midrule
R03 & Drugs For Obstructive Airway Diseases & $647,457$ & $1,972$ & $0.83$ & $0.79$–$0.87$ & $4.88 \times 10^{-12}$ \\ 
C09 & Agents Acting On The Renin-Angiotensin System & $966,365$ & $4,714$ & $0.88$ & $0.85$–$0.91$ & $1.51 \times 10^{-10}$ \\ 
N07 & Other Nervous System Drugs & $148,442$ & $200$ & $0.61$ & $0.53$–$0.71$ & $3.50 \times 10^{-10}$ \\ 
H02 & Corticosteroids For Systemic Use & $603,449$ & $1,526$ & $0.83$ & $0.79$–$0.88$ & $7.32 \times 10^{-10}$ \\ 
J01 & Antibacterials For Systemic Use & $2,344,896$ & $7,626$ & $0.90$ & $0.87$–$0.94$ & $2.57 \times 10^{-7}$ \\ 
S03 & Ophthalmological And Otological Preparations & $176,117$ & $484$ & $0.80$ & $0.73$–$0.88$ & $4.36 \times 10^{-5}$ \\ 
D07 & Corticosteroids, Dermatological Preparations & $882,736$ & $3,009$ & $0.92$ & $0.88$–$0.95$ & $4.54 \times 10^{-4}$ \\ 
P01 & Antiprotozoals & $221,934$ & $466$ & $0.82$ & $0.75$–$0.90$ & $5.86 \times 10^{-4}$ \\ 
R05 & Cough And Cold Preparations & $1,091,013$ & $3,366$ & $0.92$ & $0.89$–$0.96$ & $1.18 \times 10^{-3}$ \\ 
D02 & Emollients And Protectives & $41,420$ & $18$ & $0.46$ & $0.28$–$0.73$ & $1.87 \times 10^{-2}$ \\ 
C08 & Calcium Channel Blockers & $530,601$ & $2,656$ & $0.93$ & $0.89$–$0.97$ & $2.01 \times 10^{-2}$ \\ 
J07 & Vaccines & $224,099$ & $567$ & $0.87$ & $0.80$–$0.95$ & $2.77 \times 10^{-2}$ \\ 
L01 & Antineoplastic Agents & $45,682$ & $63$ & $0.68$ & $0.53$–$0.87$ & $2.97 \times 10^{-2}$ \\ 
L04 & Immunosuppressants & $100,729$ & $254$ & $0.82$ & $0.73$–$0.93$ & $3.24 \times 10^{-2}$ \\ 
\midrule
\multicolumn{7}{l}{drugs increasing PD risk} \\ 
\midrule
N06 & Psychoanaleptics & $720,332$ & $3,420$ & $1.81$ & $1.74$–$1.88$ & $2.52 \times 10^{-190}$ \\ 
G04 & Urologicals & $502,620$ & $3,369$ & $1.41$ & $1.36$–$1.47$ & $9.61 \times 10^{-58}$ \\ 
N05 & Psycholeptics & $1,218,642$ & $5,504$ & $1.33$ & $1.29$–$1.38$ & $1.34 \times 10^{-54}$ \\ 
A06 & Drugs For Constipation & $194,507$ & $587$ & $1.50$ & $1.38$–$1.63$ & $2.78 \times 10^{-19}$ \\ 
N03 & Antiepileptics & $273,168$ & $980$ & $1.35$ & $1.27$–$1.45$ & $6.49 \times 10^{-18}$ \\ 
C07 & Beta Blocking Agents & $739,566$ & $4,478$ & $1.17$ & $1.12$–$1.21$ & $2.09 \times 10^{-14}$ \\ 
M05 & Drugs For Treatment Of Bone Diseases & $167,178$ & $857$ & $1.23$ & $1.15$–$1.33$ & $2.89 \times 10^{-7}$ \\ 
B01 & Antithrombotic Agents & $994,342$ & $5,858$ & $1.11$ & $1.07$–$1.15$ & $4.27 \times 10^{-7}$ \\ 
A11 & Vitamins & $405,653$ & $1,255$ & $1.18$ & $1.11$–$1.25$ & $6.59 \times 10^{-7}$ \\ 
C01 & Cardiac Therapy & $318,904$ & $1,822$ & $1.15$ & $1.09$–$1.21$ & $2.99 \times 10^{-6}$ \\ 
S01 & Ophthalmologicals & $1,319,893$ & $4,914$ & $1.10$ & $1.06$–$1.14$ & $8.58 \times 10^{-6}$ \\ 
H01 & Pituitary And Hypothalamic Hormones And Analogues & $43,925$ & $81$ & $1.64$ & $1.31$–$2.04$ & $2.35 \times 10^{-4}$ \\ 
D01 & Antifungals For Dermatological Use & $394,685$ & $1,372$ & $1.12$ & $1.06$–$1.19$ & $8.01 \times 10^{-4}$ \\ 
B03 & Antianemic Preparations & $421,667$ & $1,431$ & $1.11$ & $1.05$–$1.17$ & $4.88 \times 10^{-3}$ \\ 
A12 & Mineral Supplements & $371,794$ & $1,287$ & $1.10$ & $1.04$–$1.17$ & $1.63 \times 10^{-2}$ \\ 
N02 & Analgesics & $1,867,798$ & $6,006$ & $1.06$ & $1.02$–$1.10$ & $1.74 \times 10^{-2}$ \\ 
\bottomrule
\end{longtable}
\begin{minipage}{\linewidth}
\textsuperscript{1}p-value adjusted for false discovery rate\\
\end{minipage}

